Skip to main content
. Author manuscript; available in PMC: 2021 Apr 27.
Published in final edited form as: Cancer Biomark. 2020;27(3):407–421. doi: 10.3233/CBM-190988

Table 1.

Serum sample patient population (n = 164), analyzed on western blot and ELISA

Validation set I

Patient description Number of samples Age range (Avg) (median)

Late stage HGSOC at time of diagnosis, pre-treatment 50 39–81* (62.6) (62)
Early stage HGSOC at time of diagnosis, pre-treatment 14 44–76 (58.8) (57)
Benign gynecological condition (ovarian cyst) 50 17–76 (48.8) (49.5)
Healthy volunteers from community outreach 50 32–88 (56.2) (53)

Patient population of serum samples analyzed on ELISA and western blot.

*

Indicates age not available for 5 cases.